Exelixis' cabozantinib reduces lung and thymic NET progression risk by 81%

15 hours ago 1
Read Entire Article
  1. Homepage
  2. Finance
  3. Exelixis' cabozantinib reduces lung and thymic NET progression risk by 81%

Related

Seeking Alpha Quant picks in S&P 500 real estate sector as earnings season picks up steam

Seeking Alpha Quant picks in S&P 500 real estate sector as e...

24 minutes ago 0
White House joins Bluesky, immediately roasts Democrats with sizzle reel of Trump’s first 9 months

White House joins Bluesky, immediately roasts Democrats with...

1 hour ago 0
Dodgers superstar Shohei Ohtani plays one of the greatest games in baseball history, throwing 10 strikeouts and hitting 3 home runs

Dodgers superstar Shohei Ohtani plays one of the greatest ga...

1 hour ago 0
Trump’s short-term aid ‘during this little transition’ turns into an automaker rebate running through 2030

Trump’s short-term aid ‘during this little transition’ turns...

1 hour ago 0
‘These are people who are in this country doing hard work that many Americans don’t want to do’: Farmers, schools reel from Trump immigration crackdown

‘These are people who are in this country doing hard work th...

1 hour ago 0
Lufthansa follows Ryanair to cut German flight schedule amid high fees

Lufthansa follows Ryanair to cut German flight schedule amid...

1 hour ago 0
Insider trades: CVS Health, Fastenal among major names this week

Insider trades: CVS Health, Fastenal among major names this ...

1 hour ago 0
J.B. Hunt tops weekly industrial gainers while Fastenal bleeds after Q3 results

J.B. Hunt tops weekly industrial gainers while Fastenal blee...

1 hour ago 0
Taylor Swift wearing a vintage T-shirt about sea otter conservation sparks $2 million windfall for Northern California aquarium

Taylor Swift wearing a vintage T-shirt about sea otter conse...

1 hour ago 0
Trump calls on Ukraine and Russia to ‘stop where they are’ and signals he’s leaning against giving Zelenskyy Tomahawk missiles

Trump calls on Ukraine and Russia to ‘stop where they are’ a...

1 hour ago 0
The White House has faced a flurry of rejections after inviting 9 universities to be the first signatories of its higher-ed compact

The White House has faced a flurry of rejections after invit...

1 hour ago 0
Ace Frehley was a roadie for Jimi Hendrix when he was 18 years old. A half century later, he’d sell the Kiss catalog and brand for $300 million

Ace Frehley was a roadie for Jimi Hendrix when he was 18 yea...

1 hour ago 0
BITF, ABTC, other crypto-tied stocks lead week's financials movers

BITF, ABTC, other crypto-tied stocks lead week's financials ...

2 hours ago 0
Gucci owner Kering is said to be nearing deal to sell Beauty unit to L’Oréal

Gucci owner Kering is said to be nearing deal to sell Beauty...

2 hours ago 0
Paramount Skydance reportedly speeding up mass layoffs

Paramount Skydance reportedly speeding up mass layoffs

2 hours ago 0
Notable analyst calls this week: Nvidia, T-Mobile and WMG among top picks

Notable analyst calls this week: Nvidia, T-Mobile and WMG am...

2 hours ago 0
Even the author of ‘Trumponomics’ admits ‘tariffs are taxes—and taxes are bad’

Even the author of ‘Trumponomics’ admits ‘tariffs are taxes—...

2 hours ago 0
From Iselin to India: What we learned about tariffs, trade and trust

From Iselin to India: What we learned about tariffs, trade a...

3 hours ago 0
Baker McKenzie crisis leads on risk-proofing the future: Do you have a blind spot in the boardroom?

Baker McKenzie crisis leads on risk-proofing the future: Do ...

3 hours ago 0
Roche breast cancer drug improves survival of up to 62% in late-stage trial

Roche breast cancer drug improves survival of up to 62% in l...

3 hours ago 0

Trending

1. al nassr
2. fpl
3. nick woltemade
4. mallika sherawat
5. pkl points table 2025
6. villarreal vs real betis
7. bayern vs dortmund
8. rbl bank
9. pro kabaddi
10. fulham vs arsenal

Popular

Gold ETFs see 6-fold jump in September inflows: What's driving surge?

Gold ETFs see 6-fold jump in September inflows: What's ...

3 days ago 5
GoodRx launches subscription program for men's hair loss

GoodRx launches subscription program for men's hair loss

3 days ago 5
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© FBT Company 2025. All rights are reserved